Neuromodulation Techniques in the Treatment of Chronic Tinnitus With Hearing Loss
- Conditions
- TinnitusHearing Loss
- Registration Number
- NCT01944501
- Lead Sponsor
- University of Brasilia
- Brief Summary
This study aimed at trying transcranial magnetic stimulation and transcranial direct current stimulation as potential treatments to decrease tinnitus in patients with significant hearing loss.
- Detailed Description
Tinnitus is a very common condition and affects approximately 15% of the population, disrupting sleep, emotional balance and social life of the patients. Acoustic deprivation causes hearing loss and is responsible for a cascade of processes that result in the reorganization of the cortex through a synchronization of neuronal activity related to a cortical re-mapping. Consistent with the hypothesis that tinnitus is caused by abnormal activation of the auditory cortex, repetitive transcranial magnetic stimulation (rTMS) can temporarily reduce cortical hyperactivity through direct neuromodulation of the temporal cortex. Furthermore, studies have shown that transcranial direct current stimulation (tDCS) can also suppress tinnitus. Objective: To determine the effectiveness of rTMS and TDCS in the treatment of patients with chronic tinnitus and auditory loss. Methods: We performed an analytical experimental double-blind study using rTMS and tDCS in patients with chronic tinnitus and hearing loss.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 36
- chronic tinnitus
- hearing loss
- neurological diseases
- use of drugs affecting the central nervous system
- evidence of dementia
- clinical diagnosis of depression
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in Tinnitus Handicap Inventory (THI) scores THI was measured before intervention (baseline) and after 5 daily sessions (day 5)
- Secondary Outcome Measures
Name Time Method Change in Visual Analog Scale scores Visual analog scale of tinnitus was recorded at baseline and after daily 5 TMS or TDCS sessions ( day 5)
Trial Locations
- Locations (1)
Universidade de Brasília
🇧🇷Brasília, Distrito Federal, Brazil
Universidade de Brasília🇧🇷Brasília, Distrito Federal, Brazil